^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Fibrosarcoma
    Drug:imatinib (c-KIT inhibitor, Bcr-abl tyrosine kinase inhibitor, PDGFR inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    New
    Source:
    FDA
    Excerpt:
    Gleevec is a kinase inhibitor indicated for the treatment of:...Adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP)...
    Evidence Level:
    Sensitive: A1 - Approval
    New
    Source:
    European Medicines Agency
    Excerpt:
    Imatinib Teva is indicated for...The treatment of adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery.